|
Guangdong Newdarin Biotechnology Co.,LTD.
|
MK7 is a specific form of vitamin K2 that is derived from the fermentation of soybeans or other plant sources. It is believed to be more bioavailable and have a longer half-life in the body than other forms of vitamin K2, making it an attractive ingredient for dietary supplements.
For instance, Vitamin K2 can be a great partner with calcium to improve bone and cardiovascular Health
Insufficient consumption of calcium can result in reduced bone mineral density, heightening the probability of bone fractures. Calcium supplementation can enhance bone mineral density and strength, thus preventing osteoporosis. Nevertheless, current scientific research implies that an excessive intake of calcium supplements may heighten the risk of heart disease and lead to hastened calcium accumulation in soft tissues and blood-vessel walls. Conversely, vitamin K2 has been linked to the inhibition of arterial stiffening and calcification. Adequate intake of vitamin K2 can minimize vascular damage by activating matrix GLA protein (MGP), which deters calcium deposits on walls. Vitamin K, particularly vitamin K2, is almost entirely absent in junk food and minimally consumed even in a nutritious Western diet. Inadequate activation of MGP resulting from vitamin K deficiency significantly hampers the process of calcium removal and raises the risk of blood-vessel calcification. Increasing vitamin K2 intake could potentially mitigate calcium-associated health hazards.
With advancements in manufacturing processes, the amount of vitamin K, specifically vitamin K2, found in today's food supply has significantly decreased. As a result, relying on vitamin K2 supplements is a more dependable method for ensuring sufficient intake.
Achieving a proper balance between calcium and K2 intake may help combat osteoporosis while also preventing the hardening and calcification of arteries. |
Send Inquiry
|
Pharma Sources Insight June 2024: Globalization on the Go
